M. Papamichail

D. Katritsis, M. Papamichail, E. Karvouni, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prostate cancer vaccines: the long road to clinical application

S. Perez, M. Papamichail, C. Baxevanis, 2015, Cancer Immunology, Immunotherapy.

MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4+ T-cells

S. Perez, M. Papamichail, C. Baxevanis, 2016, Oncoimmunology.

Cancer immunotherapy: perspectives and prospects.

S. Perez, M. Papamichail, 2008, Advances in experimental medicine and biology.

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

M. Papamichail, C. Baxevanis, G. Stathopoulos, 1994, Cancer.

Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients

M. Karamouzis, S. Perez, M. Papamichail, 2006, Clinical Cancer Research.

Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α

O. Tsitsilonis, G. Spanakos, A. Gritzapis, 1995, Cancer Immunology, Immunotherapy.

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide

S. Perez, M. Papamichail, C. Baxevanis, 2016, Journal of Immunotherapy for Cancer.

Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors

S. Perez, N. Kallinteris, A. Gritzapis, 2007, Cancer Immunology, Immunotherapy.

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

O. Tsitsilonis, A. Gritzapis, M. Papamichail, 2000, Journal of Immunology.

Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cells.

A. Gritzapis, M. Papamichail, C. Baxevanis, 2010, Cancer research.

Immunologic biomarkers in prostate cancer

S. Perez, M. Papamichail, C. Baxevanis, 2014, Human vaccines & immunotherapeutics.

Results from a Phase I Clinical Study of the Novel Ii-Key/HER-2/neu(776–790) Hybrid Peptide Vaccine in Patients with Prostate Cancer

S. Perez, E. von Hofe, N. Kallinteris, 2010, Clinical Cancer Research.

A HER-2/neu peptide admixed with PLA microspheres induces a Th1-biased immune response in mice.

L. Leondiadis, K. Avgoustakis, S. Perez, 2005, Biochimica et biophysica acta.

Induction of lymphokine-activated killer activity in mice by prothymosin α

N. Papadopoulos, G. Dedoussis, A. Gritzapis, 1994, Cancer Immunology, Immunotherapy.

Immunotherapy for colorectal cancer

S. Perez, M. Papamichail, C. Baxevanis, 2003 .

Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α

O. Tsitsilonis, A. Mamalaki, G. Spanakos, 1999, Cancer Immunology, Immunotherapy.

HER‐2/neu–derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes

O. Tsitsilonis, A. Gritzapis, M. Papamichail, 2002, International journal of cancer.

The localization of aggregated human -globulin in the spleens of normal mice.

E. Holborow, J. Brown, M. Papamichail, 1973, Immunology.

Studies on synovial fluid lymphocytes in rheumatoid arthritis.

E. Holborow, M. Papamichail, P. Sheldon, 1974, Annals of the rheumatic diseases.

Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice

O. Tsitsilonis, A. Gritzapis, M. Papamichail, 2000, European journal of immunology.

Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function.

S. Perez, A. Gritzapis, M. Papamichail, 2005, Cellular immunology.

In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18 1

A. Gritzapis, M. Papamichail, C. Baxevanis, 2003, The Journal of Immunology.

Effect of two thymosin fraction 5 polypeptides on human peripheral blood lymphocytes.

M. Papamichail, C. Baxevanis, D. Kokkinopoulos, 1987, Immunopharmacology and immunotoxicology.

Thymosin β4 induced phenotypic changes in Molt-4 leukemic cell line

M. Papamichail, D. Kokkinopoulos, S. Perez, 1985, Blut.

A method for analysing lymphocyte surface antigens.

M. Papamichail, J. Lambris, 1980, Journal of immunological methods.

Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis

John D Lambris, J. Lambris, C. Servis, 1989, Journal of Neuroimmunology.

Promotion of murine antitumour activity by prothymosin α treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor α

M. Papamichail, C. Baxevanis, M. Papanastasiou, 2005, Cancer Immunology, Immunotherapy.

The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.

E. Holborow, M. Papamichail, M. Peckham, 1977, British journal of experimental pathology.

Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.

E. Holborow, M. Papamichail, G. Stathopoulos, 1977, British journal of experimental pathology.

Translocation of glucocorticoid receptor from the cytoplasm into the nucleus of phytohemagglutinin-stimulated human lymphocytes in the absence of the hormone.

M. Papamichail, C. Sekeris, C. Ioannidis, 1981, Experimental cell research.

Efficacy of novel culture environments on the ex vivo expansion kinetics of cord blood progenitor cells.

A. Gritzapis, M. Papamichail, C. Baxevanis, 2002, Haematologica.

Effect of IL-21 on NK cells derived from different umbilical cord blood populations.

A. Antsaklis, S. Perez, A. Gritzapis, 2006, International immunology.

NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses

S. Perez, M. Papamichail, C. Baxevanis, 2011, The Journal of Immunology.

The use of nylon wool for the isolation of T lymphocyte subpopulations.

M. Papamichail, R. Sotiriadou, D. Kokkinopoulos, 1992, Journal of immunological methods.

Lymphocyte: Erythrocyte (L.E.) rosettes as indicators of the heterogeneity of lymphocytes in a variety of mammalian species

R. Kerbel, E. Holborow, M. Papamichail, 1975, Cell.

Thymic origin of atypical lymphoid cells in infectious mononucleosis.

E. Holborow, M. Papamichail, E. H. Hemsted, 1973, Lancet.

Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.

G. Dimitracopoulos, M. Papamichail, J. Lambris, 1982, The Journal of infectious diseases.

Release and reconstitution of Fc receptors from normal human mononuclear cells.

G. Tsokos, M. Papamichail, F. Paraskevas, 1980, Immunology.

Fluorescent labelling of proteins of lymphocyte plasma membranes.

M. Papamichail, P. Fessas, J. Lambris, 1979, Journal of immunological methods.

A simple hemagglutination method for the detection of cell surface antigens.

M. Papamichail, D. Kokkinopoulos, S. Perez, 1989, Journal of immunological methods.

A human lymphocyte mitogen extracted from the extracellular slime layer of Pseudomonas aeruginosa.

G. Dimitracopoulos, G. Tsokos, M. Papamichail, 1980, The Journal of infectious diseases.

CORONARY ARTERY DISEASE Original Studies Transcoronary Transplantation of Autologous Mesenchymal Stem Cells and Endothelial Progenitors Into Infarcted Human Myocardium

D. Katritsis, S. Perez, M. Papamichail, 2005 .

Defining the critical hurdles in cancer immunotherapy

Zhigang Tian, Sylvia Janetzki, Cedrik M Britten, 2011, Journal of Translational Medicine.

Synergy between interleukin-2 and prothymosin α for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas

A. Gritzapis, M. Papamichail, C. Baxevanis, 2000, Cancer Immunology, Immunotherapy.

Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo.

S. Perez, A. Gritzapis, M. Papamichail, 2006, Cancer research.

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence

J. Murray, E. Mittendorf, G. Peoples, 2016, Oncotarget.

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine‐activated killer cell function in patients with breast cancer

A. Gritzapis, M. Papamichail, C. Baxevanis, 1993, Cancer.

Characterization of the human effector cell causing antibody-mediated cytotoxicity

M. Papamichail, A. Temple, 1975 .

Immunoglobulins on the surface of human lymphocytes.

E. Holborow, J. Brown, M. Papamichail, 1971, Lancet.

The use of nylon fibre as a method of separating human lymphocyte subpopulations.

E. Holborow, M. Papamichail, C. Gutiérrez, 1976, Journal of immunological methods.

Binding of native and aggregated human γ-globulin by mouse lymphoid cells and fibroblasts☆

W. Faulk, M. Papamichail, C. Gutiérrez, 1979 .

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

J. Murray, E. Mittendorf, G. Peoples, 2020, Breast Cancer Research and Treatment.

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.

J. Murray, E. Mittendorf, G. Peoples, 2018, Clinical immunology.

Reduction of trapping of aggregated human IgG in germinal centers by mitogens

E. Holborow, M. Papamichail, C. Gutiérrez, 1976, European journal of immunology.

Subpopulations of human peripheral blood lymphocytes distinguished by combined rosette formation and membrane immunofluorescence.

E. Holborow, M. Papamichail, H. Currey, 1972, Lancet.

Cancer immunotherapy

S. Perez, M. Papamichail, C. Baxevanis, 2009, Critical reviews in clinical laboratory sciences.

Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA).

O. Tsitsilonis, P. Lymberi, M. Papamichail, 2004, Journal of pharmaceutical and biomedical analysis.

A skeletal muscle troponin T specific ELISA based on the use of an antibody against the soluble troponin T (16-31) fragment.

O. Tsitsilonis, D. Troy, P. Lymberi, 2002, Journal of immunological methods.

CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells*

A. Antsaklis, S. Perez, A. Gritzapis, 2005, Journal of Biological Chemistry.

Epidemiology and immunological phenotype of childhood ALL in Greece.

M. Papamichail, A. Maniatis, C. Megalakaki, 1985, Leukemia research.

A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival.

S. Perez, A. Gritzapis, M. Papamichail, 2005, Blood.

In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RI

A. Kretsovali, J. Papamatheakis, A. Mamalaki, 2003, Cancer Immunology, Immunotherapy.

Dexamethasone caused alterations in poly(A) polymerase levels of a human leukemic cell line.

M. Papamichail, C. Tsiapalis, T. Trangas, 1986, Leukemia research.

Establishment and characterization of a B-cell line from a patient with acute lymphoblastic leukemia.

S. Kottaridis, M. Papamichail, G. Pangalis, 1985, Leukemia research.

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

M. Papamichail, C. Baxevanis, P. Sotiropoulou, 2004, Cancer Immunology, Immunotherapy.

Toxicity profiles of HER2/neu peptide anticancer vaccines: the picture from Phase/I and II clinical trials

S. Perez, M. Papamichail, C. Baxevanis, 2012, Expert review of vaccines.

Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell Research

S. Perez, M. Papamichail, C. Baxevanis, 2006, Stem cells.

Immunocytochemical demonstration of glucocorticoid receptors in different cell types and their translocation from the cytoplasm to the cell nucleus in the presence of dexamethasone.

G. Tsokos, M. Papamichail, C. Sekeris, 1980, Experimental cell research.

Therapeutic cancer vaccines: a long and winding road to success

S. Perez, M. Papamichail, C. Baxevanis, 2014, Expert review of vaccines.

The effect of cytochalasin B and vinca alkaloids on EA- and EAC-rosette formation and on the binding of heat-aggregated human IgG by human lymphocytes

W. Faulk, M. Papamichail, C. Gutiérrez, 1976 .

A novel myeloid-like NK cell progenitor in human umbilical cord blood.

A. Antsaklis, S. Perez, A. Gritzapis, 2003, Blood.

Transplantation Reviews 14: Lymphocyte Immunoglobulin: Synthesis and Surface Representation

M. Papamichail, 1974 .

A novel quantitative flow cytometric method for measuring glucocorticoid receptor (GR) in cell lines: correlation with the biochemical determination of GR.

M. Alexis, S. Perez, A. Gritzapis, 2007, Journal of immunological methods.

Formation of mouse red cell rosettes by "hairy" cells.

E. Holborow, D. Catovsky, M. Papamichail, 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Multicentre evaluation of stable reference whole blood for enumeration of lymphocyte subsets by flow cytometry.

D. Belgrave, R. Thorpe, G. Janossy, 2005, Cytometry. Part B, Clinical cytometry.

Immune biomarkers: how well do they serve prognosis in human cancers?

S. Perez, M. Papamichail, C. Baxevanis, 2015, Expert review of molecular diagnostics.

AQ2 Immune biomarkers: how well do they serve as

S. Perez, M. Papamichail, I. Voutsas, 2015 .

Th1 and Th2 Serum Cytokine Profiles Characterize Patients with Hashimoto’s Thyroiditis (Th1) and Graves’ Disease (Th2)

A. Gritzapis, M. Papamichail, A. Vryonidou, 2004, Neuroimmunomodulation.

A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer

M. Karamouzis, P. Kountourakis, S. Perez, 2010, Cancer Immunology, Immunotherapy.

Polyadenylic acid metabolizing enzyme levels during induction of differentiation in a human leukemia T-cell line with phorbol ester.

M. Papamichail, C. Tsiapalis, T. Trangas, 1987, Journal of the National Cancer Institute.

HER-2/neu as a target for cancer vaccines.

S. Perez, A. Gritzapis, M. Papamichail, 2010, Immunotherapy.

Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy

A. Mamalaki, S. Perez, A. Gritzapis, 2010, Cancer Immunology, Immunotherapy.

Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties1

S. Perez, A. Gritzapis, M. Papamichail, 2008, The Journal of Immunology.

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy

S. Perez, M. Papamichail, C. Baxevanis, 2009, Cancer Immunology, Immunotherapy.

Immunogenic HER-2/neu peptides as tumor vaccines

S. Perez, A. Gritzapis, M. Papamichail, 2005, Cancer Immunology, Immunotherapy.

Inhibition of complement-dependent rosette formation after lymphocyte incubation with fatty acids.

A. D. Smith, M. Pepys, G. Tsokos, 1979, Immunology.

A colorimetric assay for the determination of 5'-nucleotidase activity.

M. Papamichail, N. Courtis, C. Tsiapalis, 1987, Journal of immunological methods.

A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit

H. Kalbacher, S. Perez, M. Papamichail, 2015, Cancer Immunology, Immunotherapy.

T- and B-cell subpopulations in infectious mononucleosis.

E. Holborow, M. Papamichail, P. Sheldon, 1974, Clinical and experimental immunology.

Evidence for distinct epitopes on human IgG with T cell proliferative and suppressor function

M. Papamichail, C. Baxevanis, M. Papamichail, 1986, European journal of immunology.

The structural requirements for immunoglobulin aggregates to localize in germinal centres.

E. Holborow, M. Papamichail, P. Embling, 1978, Immunology.

Enhanced human lymphokine‐activated killer cell function after brief exposure to granulocyte‐macrophage–colony stimulating factor

N. Papadopoulos, G. Dedoussis, M. Papamichail, 1995, Cancer.

with Potent Antitumor Properties HLA-A*0201-Binding Epitope of HER-2/neu Identification of a Novel Immunogenic

S. Perez, M. Papamichail, C. Baxevanis, 2013 .

Potent Antitumor Properties neu HLA-A * 0201-Binding Epitope of HER-2 / Identification of a Novel Immunogenic

S. Perez, A. Gritzapis, M. Papamichail, 2008 .

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors

S. Perez, M. Papamichail, C. Baxevanis, 2003, Cancer Immunology, Immunotherapy.

Invariant chain-peptide fusion vaccine using HER-2/neu.

G. Peoples, S. Perez, M. Papamichail, 2014, Methods in molecular biology.

AE37: a novel T-cell-eliciting vaccine for breast cancer

E. Mittendorf, G. Peoples, S. Perez, 2011, Expert opinion on biological therapy.

HER-2/neu-derived peptide 884–899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4+ T cell clones

G. Pawelec, A. Mamalaki, W. Voelter, 2001, Cancer Immunology, Immunotherapy.

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

E. Mittendorf, G. Peoples, S. Perez, 2015, Journal of Immunotherapy for Cancer.

Natural killer lymphocytes: biology, development, and function

S. Perez, A. Gritzapis, M. Papamichail, 2004, Cancer Immunology, Immunotherapy.

New insights into the role of NK cells in cancer immunotherapy

S. Perez, M. Papamichail, C. Baxevanis, 2012, Oncoimmunology.

Immunological studies in a case of T-cell leukaemia

E. Holborow, D. Catovsky, M. Papamichail, 1974, Journal of clinical pathology.

Immunological studies inacaseofT-cell leukaemia

D. Catovsky, M. Papamichail, E. Wiltshaw, 1974 .

Comparison of recurrent and nonrecurrent breast cancer patients undergoing AE37 peptide vaccine therapy.

E. Mittendorf, G. Peoples, S. Perez, 2014 .

The detection of glucocorticoid receptors in breast cancer by immunocytochemical and biochemical methods

N. Agnanti, M. Papamichail, J. Garas, 1982, International journal of cancer.

Immunocytochemical Detection of Glucocorticoid Receptors in Lymphocytes and Breast Tumor Cells

N. Agnanti, M. Papamichail, J. Garas, 1983 .

Loss and reappearance of transferrin receptors in human leukemic cell lines.

M. Papamichail, C. Ioannides, S. Filli, 1986, Experimental cell biology.

Primary analysis of the prospective, randomized, phase II trial of GP2+GM-CSF vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.

J. Murray, E. Mittendorf, G. Peoples, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prothymosin α restores depressed allogeneic cell‐mediated lympholysis and natural‐killer‐cell activity in patients with cancer

M. Papamichail, C. Baxevanis, M. Papamichail, 1993, International journal of cancer.

Clinical cytometry in Europe, 2005

J. Gratama, M. Papamichail, S. Papa, 2005 .

Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy.

M. Papamichail, C. Baxevanis, M. Papamichail, 1994, Critical reviews in oncology/hematology.

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.

J. Murray, E. Mittendorf, G. Peoples, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Developing effective cancer vaccines.

S. Perez, M. Papamichail, C. Baxevanis, 2011, European journal of cancer.

A method of increasing EA positive cells in mouse spleen lymphocytes.

M. Papamichail, M. Pavlatou, 1977, JIM - Journal of Immunological Methods.

Letter: Origin of malignant cells in lymphoma apparently originating in anterior mediastinum.

E. Holborow, M. Papamichail, E. Wiltshaw, 1974, Lancet.

Polyadenylic acid polymerase activity in normal and leukemic human leukocytes.

G. Pangalis, M. Papamichail, N. Courtis, 1984, Cancer research.

Therapeutic cancer vaccines: a long and winding road to success

S. Perez, M. Papamichail, C. Baxevanis, 2014, Expert Review of Vaccines.

Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes.

G. Spanakos, M. Papamichail, C. Baxevanis, 1997, British Journal of Cancer.

NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses

S. Perez, M. Papamichail, C. Baxevanis, 2011, The Journal of Immunology.

Peptide HER2(776–788) represents a naturally processed broad MHC class II-restricted T cell epitope

G. Pawelec, S. Heinzel, A. Mamalaki, 2001, British Journal of Cancer.

CORONARY ARTERY DISEASE Original Studies Transcoronary Transplantation of Autologous Mesenchymal Stem Cells and Endothelial Progenitors Into Infarcted Human Myocardium

D. Katritsis, S. Perez, M. Papamichail, 2005 .

Transplantation Review number 16: T and B Lymphocytes in Humans

M. Papamichail, 1974 .

Subgroup efficacy evaluation of the AE37 HER2 vaccine in breast cancer patients in the adjuvant setting.

E. Mittendorf, G. Peoples, J. Litton, 2017 .

The prognostic value of alpha-thymosins in breast cancer.

C. Markopoulos, J. Gogas, O. Tsitsilonis, 1998, Anticancer research.

An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.

N. Papadopoulos, G. Dedoussis, G. Spanakos, 1994, Journal of immunological methods.

CD4+CD25+ Regulatory T-Cell Frequency in HER-2/neu (HER)-Positive and HER-Negative Advanced-Stage Breast Cancer Patients

S. Perez, M. Papamichail, C. Baxevanis, 2007, Clinical Cancer Research.

Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.

G. Dedoussis, A. Gritzapis, M. Papamichail, 1994, British Journal of Cancer.

Early efficacy analysis of the AE37 vaccine in patients with HER2 low-expressing and triple-negative breast cancer.

J. Murray, G. Peoples, S. Perez, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.